Viking Global VKIN-300 Wins French LNE Attestation, Valid to 2031

Viking Global Technologies, Inc. (OTCQB: VGTK) said on 3 November 2026 that its indirect majority-owned subsidiary Viking Ozone Technology, LLC received a formal Attestation of Conformity, No. 41506-0, from Laboratoire national de métrologie et d'essais for the VKIN-300 ozone-based medical and biohazardous waste treatment system. The attestation was issued on 28 October 2026 for the VKIN 300 SD configuration, runs through 27 October 2031, and may be renewed once. The certified process requires a minimum average ozone concentration of 3,500 parts per million across a 45-minute cycle.

Context — why the French attestation matters now

The attestation closes a regulatory sequence the company has been flagging for weeks. On 5 October 2026, Viking announced that the French government had formally incorporated standard NF X30-503-1:2024 into its regulatory framework governing equipment used for the pretreatment by disinfection of infectious healthcare waste. That amendment removed an outstanding requirement that had blocked formal conformity documentation for the VKIN-300.

At the time, the company told investors LNE's Technical Committee review was scheduled for 14 October 2026 and that formal documentation could arrive by the end of October, subject to remaining review procedures. The attestation landed on 28 October 2026, inside that window and for the certified equipment configuration.

What changed is the regulatory basis itself. French authorities did not simply review the VKIN-300 against an existing rulebook; they wrote the applicable standard into the framework first, then the national laboratory assessed the machine against it. For a small-cap developer, that sequencing matters because it means the target the equipment had to hit was set by the regulator rather than by the company.

Viking has not disclosed what it spent on the conformity process, and it has not quantified any revenue tied to the attestation. The report frames the milestone as the end of years of engineering development, independent testing and technical evaluation, and as the start of a commercialization push rather than as a commercial event in itself.

The macro backdrop is not addressed in the report, and no market data accompanies the filing, so the read here is company-specific: a regulatory gate has opened, and the question shifts from whether the technology can be certified to whether it can be sold.

Data — what the numbers show

The concrete figures in the announcement are regulatory rather than financial. Attestation No. 41506-0 was issued 28 October 2026 and expires 27 October 2031, a five-year validity with a single renewal option. The certified configuration is the VKIN 300 SD. The reference standard is NF X 30-503-1:2024.

The treatment specification is the most operationally specific number: a minimum average ozone concentration of 3,500 ppm sustained across a 45-minute cycle. That is the dose LNE certified, and it is the parameter a buyer, installer or inspector would verify against in the field.

Item	Detail
Attestation number	41506-0
Issued	28 October 2026
Valid through	27 October 2031
Certified configuration	VKIN 300 SD
Reference standard	NF X 30-503-1:2024
Certified ozone dose	3,500 ppm average, 45-minute cycle

LNE's accompanying evaluation report records satisfactory findings across the applicable assessments: biological-indicator treatment, infectious-waste treatment, microbial regrowth, airborne microbial contamination and particle-size testing. Those are pass/fail categories rather than graded scores, and the company did not publish the underlying measurements.

No share price, market capitalization, revenue figure or order book is given in the report, and none is supplied by the market data available here, so no valuation comparison is possible from these facts alone. What the numbers do establish is scope: the attestation covers one configuration under one national framework, and the company states plainly that it is not regulatory approval in any other jurisdiction.

Analysis — what it means for medical waste and small-cap tech

The attestation matters less as a headline than as a sales instrument. Healthcare institutions and waste-management operators buying capital equipment generally require evidence that a device meets a recognized standard before procurement review begins. A national laboratory attestation with a five-year validity and a defined ozone dose gives Viking Ozone a document it can put in front of those buyers.

The second-order effect runs through the competitive set. Conventional treatment in this category relies on incineration and autoclaving, both of which the company positions the VKIN-300 against. If ozone treatment gains traction in France, the pressure lands on incumbents selling those methods into French hospitals and on the logistics of hauling infectious waste off site.

The counter-argument is straightforward and the company states it. The attestation applies specifically to the VKIN 300 SD configuration under French requirements. Commercial deployment remains subject to regulatory requirements, customer demand, financing, manufacturing and installation capabilities, and other commercial considerations. The company adds that there can be no assurance the attestation will result in purchase orders, revenue or commercial adoption.

Renewal is another limitation. The attestation may be renewed once and its validity can be called into question if product requirements change or the equipment is modified, which constrains how freely Viking can iterate on the certified configuration without reopening the review.

On positioning, the report gives no ownership, short interest or flow data, so no read on who holds the stock is possible from these facts. What can be said is directional: the announcement removes a regulatory overhang that had been live since at least early October, and management's stated priority is now converting the certification into commercial progress.

Outlook — what to watch next

Three things carry the story from here. First, whether Viking Ozone converts the attestation into disclosed customer engagements with healthcare institutions, waste-management organizations, distributors or strategic partners. The company names those groups as targets but has announced no signed agreements.

Second, the international reference value of the French process. Viking says the independent validation may serve as a technical and regulatory reference as it and its partners pursue other markets, subject to local requirements and approvals. Any filing or certification in a second jurisdiction would be the test of that claim.

Third, the maintenance conditions attached to the attestation itself. Any modification to the VKIN 300 SD, or any change in applicable product requirements, puts validity in question, and the renewal option is limited to one. The report gives no scheduled dates for renewal review or for the next LNE action, so there is no calendar catalyst to track.

Frequently Asked Questions

What is an Attestation of Conformity from LNE?

It is formal documentation issued by Laboratoire national de métrologie et d'essais, France's national laboratory for metrology and testing, which the French Ministry of Social Affairs and Health approves to issue such attestations. For the VKIN-300, it confirms the equipment meets the regulatory and normative requirements identified in the attestation, including French standard NF X 30-503-1:2024. It is not approval in any other jurisdiction.

Does the VKIN-300 attestation mean Viking has sales in France?

No. The company states there can be no assurance the attestation will result in purchase orders, revenue or commercial adoption. Viking Ozone says it intends to keep engaging prospective customers, distributors and strategic partners, and management describes translating the achievement into commercial progress as its priority. The report discloses no signed contracts, order volumes or revenue tied to the certification.

What are the conditions that could invalidate the attestation?

The attestation is valid through 27 October 2031 and may be renewed once. It remains subject to continuing requirements, and its validity may be called into question if applicable product requirements change or if the equipment is modified. Because it covers the VKIN 300 SD configuration specifically, changes to that configuration would fall outside the certified scope as issued.

Bottom Line

Viking Ozone's French certification opens a five-year commercial window, but revenue still depends on buyers it has not yet signed.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.